GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Spectrum Pharmaceuticals, Inc. (SPPI) [hlAlert]

Rating:
Mkt Outperform
SPPI
down 12.39 %

Spectrum Pharmaceuticals, Inc. (SPPI) rated Mkt Outperform with price target $12 by Burrill Institutional Research

Posted on: Wednesday,  May 29, 2013  8:25 AM ET by Burrill Institutional Research

Burrill Institutional Research rated Mkt Outperform Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) on 05/29/2013, when the stock price was $8.55.
Since then, Spectrum Pharmaceuticals, Inc. has lost 12.40% as of 12/04/2015's recent price of $7.49.
If you would have followed this Burrill Institutional Research's recommendation on SPPI, you would have lost 12.39% of your investment in 919 days.

Spectrum Pharmaceuticals, Inc. ( Spectrum) is a commercial stage biopharmaceutical company, engaged in developing and commercializing therapies with a focus primarily in the areas of hematology-oncology and urology. The Company?s product is apaziquone (formerly EOquin), which is in two Phase 3 clinical trials for non-muscle invasive bladder cancer under a collaboration with Allergan Inc. Another drug, ozarelix is in a Phase 2 clinical trial for benign prostatic hypertrophy (BPH). On December 15, 2008, Spectrum and Cell Therapeutics, Inc. (CTI) partnered to form a joint venture, RIT Oncology, LLC (RIT), to develop Zevalin ([90Y]-ibritumomab tiuxetan) in the United States. Its subsidiaries include OncoRx Pharma Private Limited, Spectrum Pharmaceuticals GmbH, RIT Oncology, LLC and Spectrum Pharma Canada. During the year ended December 31, 2008, the Company dissolved NeoJB LLC.

Burrill Institutional Research
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/29/2013 8:25 AM Buy
None
8.55 12.00
as of 12/13/2013
1 Week down  -3.38 %
1 Month down  -1.93 %
3 Months up  13.71 %
1 YTD up  6.66 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy